Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Cystinuria Pilot
NCT02538016Completed
- Start
- Oct 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tolvaptan in cystinuria (CSNU). Primary endpoint: Urinary Cystine Supersaturation. Started Oct 2016; status: completed.
02
Drugs
tolvaptan
03
Conditions
cystinuria (CSNU)
Beyond the preview
Go deeper on NCT02538016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02538016.